Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexsero for Prevention of Gonococcal Infections in MSM
jRCTs031240617Recruiting
- Start
- Aug 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial of meningococcal group B vaccine in gonorrhea (2 arms). Primary endpoint: Primary efficacy endpoint. Started Aug 2026; status: recruiting.
02
Drugs
meningococcal group B vaccine
03
Conditions
gonorrhea
Beyond the preview
Go deeper on jRCTs031240617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031240617.